Reaction of 4-methylumbelliferylguanidinobenzoate with proteases in plasma of patients with cystic fibrosis.

Protease activity, assayed using 4- methylumbelliferylguanidinobenzoate, an active site titrant of certain 
proteases, is significantly deficient in plasma of patients with cystic fibrosis. 
The deficiency can be demonstrated with both chloroform-ellagic acid activated plasma 
in which the proteases can hydrolyze esters of arginine and unactivated 
plasma in which the proteases have negligible activity towards these esters. 
The deficiency can also be demonstrated by separation of the proteases 
by isoelectric focusing on polyacrylamide gels or by chromatography on agarose 
columsn. Since protease deficiency can be demonstrated with unactivated plasma, the 
deficiency in cystic fibrosis is probably due to a reduced number 
of protease molecules rather than their decreased catalytic efficiency. 